ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

CTEP-Approved Trials For the Month of June

June 28, 2013

NCI Renews City of Hope’s Comprehensive Cancer Center Designation.

May 30, 2008

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Worker Health RFA May Finally Be Ready

August 26, 1988

Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made

March 2, 1984

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998